【国内1位】医療用医薬品に集中。がん領域の新薬開発に注力。
日付 | 信用売残 (解説) | 信用買残 (解説) | 信用倍率 (解説) |
---|---|---|---|
2022/5/20 | 297,500 | 2,598,000 | 8.73 |
2022/5/13 | 240,900 | 2,643,000 | 10.97 |
2022/4/28 | 331,500 | 2,503,200 | 7.55 |
2022/4/22 | 343,800 | 2,723,000 | 7.92 |
2022/4/15 | 350,500 | 2,385,400 | 6.81 |
2022/4/8 | 303,600 | 2,829,000 | 9.32 |
2022/4/1 | 1,251,600 | 3,863,100 | 3.09 |
2022/3/25 | 1,097,300 | 4,034,700 | 3.68 |
2022/3/18 | 1,047,400 | 5,186,000 | 4.95 |
2022/3/11 | 1,038,600 | 6,254,800 | 6.02 |
2022/3/4 | 133,600 | 6,301,900 | 47.17 |
2022/2/25 | 160,300 | 6,403,400 | 39.95 |
2022/2/18 | 217,900 | 6,392,100 | 29.34 |
2022/2/10 | 258,300 | 6,700,500 | 25.94 |
2022/2/4 | 183,900 | 7,585,600 | 41.25 |
2022/1/28 | 204,200 | 7,855,400 | 38.47 |
2022/1/21 | 250,600 | 8,044,700 | 32.10 |
2022/1/14 | 251,800 | 8,451,800 | 33.57 |
2022/1/7 | 146,600 | 9,211,200 | 62.83 |
2021/12/30 | 139,900 | 9,863,500 | 70.50 |
2021/12/24 | 156,300 | 10,362,700 | 66.30 |
2021/12/17 | 220,800 | 10,643,100 | 48.20 |
2021/12/10 | 325,800 | 11,142,500 | 34.20 |
2021/12/3 | 235,600 | 10,971,900 | 46.57 |